Understanding Challenges, Behavioral Patterns, and Preferences Toward Participation in Clinical Trials in Minority Patient Populations: Development of a Personalized Clinical Trial Educational Platform to Increase Participation in Clinical Trials Among Underserved Cancer Patients
Understanding the Challenges, Behavioral Patterns, and Preferences Towards Participation in Clinical Trials in Minority Patient Populations: Development and Validation of a Personalized Clinical Trial Educational Platform to Boost Participation Among Underserved Cancer Patients
Sponsor: Mayo Clinic
This NA trial investigates Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm and is currently ongoing. Mayo Clinic leads this study, which shows 13 recorded versions since 2019 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
13 versions recorded-
Jan 2026 — Present [monthly]
Active Not Recruiting NA
-
Aug 2025 — Jan 2026 [monthly]
Active Not Recruiting NA
-
Feb 2025 — Aug 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 8 earlier versions
-
Nov 2023 — Jul 2024 [monthly]
Recruiting NA
-
Jun 2023 — Nov 2023 [monthly]
Recruiting NA
Phase: None → NA
-
Feb 2023 — Jun 2023 [monthly]
Recruiting
-
Dec 2022 — Feb 2023 [monthly]
Recruiting
-
Dec 2021 — Dec 2022 [monthly]
Recruiting
-
Jun 2021 — Dec 2021 [monthly]
Recruiting
-
Jan 2021 — Jun 2021 [monthly]
Recruiting
-
Dec 2020 — Jan 2021 [monthly]
Recruiting
First recorded
Oct 2019
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mayo Clinic
For direct contact, visit the study record on ClinicalTrials.gov .